About Joyn Bio
Joyn Bio is a company based in Boston (United States) founded in 2017. Joyn Bio has raised $100 million across 1 funding round from investors including Bayer, Ginkgo Bioworks and Viking Global Investors. The company has 72 employees as of December 31, 2022. Joyn Bio operates in a competitive market with competitors including Ginkgo Bioworks, Zymergen, AgBiome, Pluton Biosciences and Ascribe Bioscience, among others.
- Headquarter Boston, United States
- Employees 72 as on 31 Dec, 2022
-
Sectors
Chemicals & MaterialsAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Joyn Bio Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$100 M (USD)
in 1 rounds
-
Latest Funding Round
$100 M (USD), Series A
Mar 20, 2018
-
Investors
Bayer
& 2 more
-
Employee Count
72
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Joyn Bio
Unlock access to complete
Unlock access to complete
Board Team
4 people
Lead Team
1 people
Operations Team
1 people
Scientist Team
1 people
Research Team
1 people
Unlock access to complete
Funding Insights of Joyn Bio
Joyn Bio has successfully raised a total of $100M through 1 strategic funding round. The most recent funding activity was a Series A round of $100 million completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Joyn Bio
Joyn Bio has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Bayer, Ginkgo Bioworks and Viking Global Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private investment firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Life science solutions for healthcare and agriculture are delivered.
|
Locked | Locked | Locked | |
|
Gene editing-based cultured ingredients are provided for agriculture.
|
Locked | Locked | Locked |
Investor details for Joyn Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Joyn Bio
Investment portfolio details for Joyn Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Joyn Bio
Detailed financials for Joyn Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Joyn Bio Comparisons
Peer comparison for Joyn Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Joyn Bio
Joyn Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ginkgo Bioworks, Zymergen, AgBiome, Pluton Biosciences and Ascribe Bioscience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| Locked | Locked | Locked |
Provider of microbe-based diversified farm inputs
|
|
| Locked | Locked | Locked |
Provider of microbe-based crop protection solutions
|
|
| Locked | Locked | Locked |
Assay-based microbial research services are offered for industrial applications.
|
|
| Locked | Locked | Locked |
Microbe-based biological inputs for crop pathogen control are developed.
|
|
| Locked | Locked | Locked |
Manufacturer and supplier of biological agrochemicals
|
Detailed competitors of Joyn Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Joyn Bio
Complete news archive for Joyn Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Joyn Bio
Joyn Bio was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Joyn Bio is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Michael Miille is the current CEO of Joyn Bio.
Joyn Bio is a funded company, having raised a total of $100M across 1 funding round to date.
As of Dec 31, 2022, the latest employee count at Joyn Bio is 72.
Joyn Bio was founded in 2017 and is based in Boston, United States. Microbial strains of soil nitrogen-fixing bacteria are developed by the company to deliver essential nitrogen levels to crops. Genes enabling this function are incorporated into the strains using synthetic biology techniques. Operations focus on biofertilizer production within the agricultural biotechnology sector, supporting sustainable crop nutrition practices.
Joyn Bio's top competitors include Ginkgo Bioworks, Zymergen and Ascribe Bioscience.
Joyn Bio has 3 investors. Key investors include Bayer, Ginkgo Bioworks, and Viking Global Investors.